Results 151 to 160 of about 65,843 (240)

Two Cases of Bilateral Ureteral Metastases From Prostate Cancer Initially Presenting With Postrenal Acute Kidney Injury

IJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction Although prostate‐specific antigen (PSA) screening has facilitated early detection of prostate cancer, approximately 5% of patients still present with distant metastases at diagnosis. Ureteral metastasis from prostate cancer is extremely rare.
Hiroshi Ushida, Ryo Ikari, Hiromu Tokuchi, Yumi Manabe   +3 more
wiley   +1 more source

The genetics of cancer heterogeneity and mesothelioma. [PDF]

Front Oncol
Chirieac LR, Gill R, Attanoos R.
europepmc   +1 more source

Solid-variant primary pulmonary adenoid cystic carcinoma with pleural metastasis and malignant pleural effusion: a rare case report. [PDF]

Front Oncol
Guo S, Zhai Y, Gao H, Ding C.
europepmc   +1 more source

A Case of Disseminated Nocardiosis due to Nocardia otitidiscaviarum With Pulmonary Infection and a Thyroid Abscess

Respirology Case Reports, Volume 14, Issue 7, July 2026.
Nocardia otitidiscaviarum is a rare pathogen worldwide compared with other Nocardia species. Although Nocardia infections occur mainly in immunocompromised individuals and typically involve lungs and skin, cases in immunocompetent hosts have also been reported in recent years.
Seigo Miyoshi, Miyuki Tanabe, Tetsuya Yamamoto, Mayuko Semba, Chika Sato, Akira Watanabe, Sohei Kitazawa, Ryoji Ito   +7 more
wiley   +1 more source

Outcomes of radiologically diagnosed solitary fibrous tumours of the pleura. [PDF]

ERJ Open Res
Ellayeh M, Mercer R, Alqarooni S, Sharaf Z, Dack G, Shatti D, Arnold D, Chen L, Cowell GW, Stockbridge A, Aujayeb A, Wing L, Benamore R, Rahman NM.   +13 more
europepmc   +1 more source

Lobe‐Specific Versus Systematic Lymph Node Dissection in Clinical Stage I Non‐Small Cell Lung Cancer: A Propensity Score‐Matched Analysis Based on the 8th Edition of the TNM Stage Classification

Thoracic Cancer, Volume 17, Issue 13, July 2026.
In this propensity score‐matched study of clinical stage I non‐small cell lung cancer, lobe‐specific lymph node dissection achieved comparable overall and relapse‐free survival to systematic lymph node dissection while reducing operative invasiveness and postoperative supraventricular tachyarrhythmia.
Hirotsugu Notsuda, Ken Onodera, Sakiko Kumata, Satoshi Kamata, Toru Kawakami, Tatsuaki Watanabe, Yui Watanabe, Takashi Hirama, Takaya Suzuki, Hisashi Oishi, Hiromichi Niikawa, Yoshinori Okada   +11 more
wiley   +1 more source

Isolated Pleural Effusion as Presentation of a Large B-Cell Lymphoma: A Case Report and Diagnostic Considerations. [PDF]

J Clin Lab Anal
Magalie VV, Rosina D, Lucienne M, Wim D, Sophie VA, Helena C.   +5 more
europepmc   +1 more source

Transformation or Clonal Evolution? A Rare Case Report of Pulmonary Sarcomatoid Carcinoma Developing to Small Cell Lung Cancer

Thoracic Cancer, Volume 17, Issue 13, July 2026.
This is the first reported case of pulmonary sarcomatoid carcinoma undergoing conversion to small cell lung cancer. Genetic profiling of serial biopsies suggests clonal evolution or alternative transformation mechanisms. ABSTRACT Many cases of non‐small cell lung cancer (NSCLC) transforming to small cell lung cancer (SCLC) after targeted therapy have ...
Wen Jiang, Yuwei Zhang, Xingmei Li, Qi Si, Zhaohuan Ye, Youfeng Ma, Haitao Zhou, Jianwei Huang, Chao Zhang, Ge Zhang   +9 more
wiley   +1 more source

The Role of CEUS in the Diagnosis and Follow-Up of Pleuropulmonary Diseases and Interventional Procedures. [PDF]

J Clin Med
Boccatonda A, Brighenti A, Piamonti D, Bandini G, Fiorini G, Vetrugno L, Marchetti G, Accogli E, Serra C, D'Ardes D.   +9 more
europepmc   +1 more source

BAP1 Loss Might Be a Predictive Biomarker for Immunotherapy Response in Pleural Mesothelioma

Thoracic Cancer, Volume 17, Issue 13, July 2026.
We evaluated whether BAP1 loss is associated with clinical outcomes following immunotherapy. BAP1 loss shows better progression‐free survival (PFS), but we can't conclude that BAP1 loss is a favorable predictive biomarker. The reason is that BAP1 loss may have a better baseline prognosis, and it is necessary to consider the interactions with other ...
Reina Imase, Rie Sakakibara, Susumu Kirimura, Hironori Ishibashi, Kenichi Okubo, Yasunari Miyazaki   +5 more
wiley   +1 more source